🔎 Trials Near Me

Akèy › Limfòm Burkitt › Pennsylvania › Philadelphia

Etid klinik pou Limfòm Burkitt nan Philadelphia, PA

16 etid pou Limfòm Burkitt ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Ap rekriteFaz 3
  • Children's Hospital of Philadelphia (Data Collection Only), Philadelphia
Laj 1 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07223021

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Ap rekriteFaz 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi lwen
366 Days – 46 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Ap rekriteFaz 3
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Laj 18 a 39 · Tout sèks · Mizajou Oct 2, 2026 · NCT03150693

Blinatumomab Consolidation in Real World

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Ap rekriteEtid obsèvasyon
  • Children's Hospital of Philadelphia, Philadelphia
Laj 0 a 38 · Tout sèks · Mizajou Oct 1, 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Ap rekriteFaz 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi lwen
365 Days · Tout sèks · Mizajou Sep 25, 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Ap rekriteFaz 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Ap rekriteFaz 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi lwen
Laj 1 a 30 · Tout sèks · Mizajou Sep 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Ap rekriteFaz 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi lwen
365 Days – 25 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Ap rekriteFaz 2
  • Children's Hospital of Philadelphia, Philadelphia
Laj 7 a 25 · Tout sèks · Mizajou Aug 19, 2026 · NCT05082519

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Ap rekrite
  • Children's Hospital of Philadelphia, Philadelphia
Jiska laj 25 · Tout sèks · Mizajou Jul 8, 2026 · NCT03810196

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

Ap rekriteFaz 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Laj 0 a 29 · Tout sèks · Mizajou May 26, 2026 · NCT05480449

Co-administration of CART22-65s and huCART19 for B-ALL

Ap rekriteFaz 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Jiska laj 29 · Tout sèks · Mizajou Mar 27, 2026 · NCT05674175

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Ap rekriteFaz 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Laj 15 a 50 · Tout sèks · Mizajou Sep 9, 2025 · NCT04150497

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Ap rekriteFaz 2
  • Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington · 25 mi lwen
Laj 1 a 25 · Tout sèks · Mizajou May 4, 2025 · NCT03509961

Etid Limfòm Burkitt nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.